Navigation Links
Researchers shed light on mechanism of action used by anti-cancer drug

otein disposition. When stressed in this way, the cell responds to the protein load by reducing protein synthesis, increasing levels of protein chaperones, and by accelerating protein degradation. However, according to Grant, when ER stress exceeds a certain threshold, the ER stress response is converted from an adaptive to a pro-death response.

The team observed that exposure of cells to sorafenib resulted in the pronounced phosphorylation of a protein known as eIF2á, a process that serves as a critical brake on protein translation in cells subjected to ER stress. Interestingly, they also found that sorafenib, by virtue of its ability to inhibit Raf, also prevented an increase in expression of a chaperone protein known as Grp78, which is classically induced in the ER stress response, and which helps to resolve stresses associated with increased protein loads. The net effect of these actions was to induce a shutdown of protein synthesis accompanied by a dramatic increase in cell death.

“The notion that sorafenib acts by inhibiting protein synthesis and reducing expression of Mcl-1 suggests that this agent might be logically combined with other targeted agents whose antitumor activity is limited by Mcl-1 expression,” Grant said. Several such targeted agents are currently undergoing clinical evaluation in patients with various malignancies.


'"/>

Source:Virginia Commonwealth University


Page: 1 2

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
(Date:10/9/2008)...ean Molecular Biology Laboratory (EMBL) have gener...te developmental blueprint of a vertebrate. With a...he first time track all cells for the first 24 hou...tructed into a three-dimensional, digital represen...current online issue of Science , grants many new...
(Date:10/9/2008)...008 The Indonesian government and World Wildlife ...otect the remaining forests and critical ecosystem... of the world,s most diverse and endangered fore...ver island-wide commitment to protect Sumatra,s st...ndorsed by governors of all provinces across Sumat...
(Date:10/9/2008)...rgy and Infectious Diseases (NIAID), part of the N...e-year contracts estimated to be up to $68.7 milli...fectious Disease Research at four research institu...l techniques to study diseases that include severe...nd influenza. , Systems biology is the study of ...
(Date:10/9/2008)...arolina State University is leading to a new kind ...om freshwater ponds, instead of from the sea. , ...use the pond-raised crabs look and taste just like... native blue crab population has been at historic ...C State,s Center for Marine Sciences and Technolog...
Breaking Biology News(10 mins):Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate 2Saving Sumatra: Indonesia reaches historic agreement 2New Systems Biology Awards enable detailed study of microbes 2Turning freshwater farm ponds into crab farms 2Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25 2007 1282 1Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25 2007 1282 2Rigel to Present Research Programs at Scientific Conferences 1279 1Rigel to Present Research Programs at Scientific Conferences 1279 2Rigel to Present Research Programs at Scientific Conferences 1279 3Anesiva Announces Pivotal Phase 3 Trial of Zingo 28TM 29 Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults 528 1Anesiva Announces Pivotal Phase 3 Trial of Zingo 28TM 29 Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults 528 2Anesiva Announces Pivotal Phase 3 Trial of Zingo 28TM 29 Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults 528 3Anesiva Announces Pivotal Phase 3 Trial of Zingo 28TM 29 Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults 528 4Anesiva Announces Pivotal Phase 3 Trial of Zingo 28TM 29 Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults 528 5Get Ripped with New iROW Workout 3760 1Get Ripped with New iROW Workout 3760 2
... old child, born deaf but with a cochlear implant ...r. That,s the most complex speech the child uttere... a toy train set. , In contrast, a child of the s...er made more sophisticated statements: "OK, now th...ow -- Woo! Woo!" and "OK, the train,s coming to ge...
...nderson Cancer Center have significantly refined t...he process of self-destruction - an advance they s...therapies. , , In the June 30 issue of the jour...brake" exists in a cell to prevent it from undergo...say that optimal anti-cancer therapies should take...
...cer patients without incurring side effects such a...e method, produced at the University of Bath, Engl...n the chemotherapy drug which are then implanted i...hese fibres are bio-degradable and compatible with...ed by the patient,s body. They gradually turn from...
...ncer-causing virus that was thought to be unimport...ed by the virus to initiate an infection and to re...ropic virus type 1 (HTLV-1) and a protein it makes...alled accessory proteins, proteins that earlier st...t the virus could live without. , But this new s...
Other Biology News:With cochlear implants, earlier use leads to better speech 2With cochlear implants, earlier use leads to better speech 3Researchers find molecular 'brake' to cell death 2Researchers find molecular 'brake' to cell death 3New device could cut chemotherapy deaths 2Cancer virus protein needed for successful infection 2
(Date:10/10/2008)...hed the Sixth Milestone in its Ofatumumab ...N, Denmark, October 10 /- G...d the sixth milestone for,ofatumumab (HuMax-CD20(R...SmithKline (GSK). A milestone payment of approxima...) was triggered by the first patient,receiving tre...
(Date:10/10/2008)...Oct. 10 /Xinhua-- Beike,Biotechnology...bal leader in,stem cell research and treatment thr...as signed eight separate mutual cooperation agreem...anding stem cell research organizations.,As part o...em Cell Expert,Advisory Committee" and a separate ...
(Date:10/10/2008)...RNewswire/ -- Twenty of Britain,s most,innovative ...bit their,ideas at the fifth annual SETsquared Par...eld at One Great George Street, London, from 8am o...m of technology innovators,in electronics, informa...Six companies will give 10-minute presentations to...
(Date:10/10/2008)...Newswire/ -- Takeda Pharmaceutical Company,Limited...earch and,Development Center, Inc., a wholly owned...ation that the U.S. Food and Drug Administration (...e alogliptin New Drug Application,(NDA) by the Pre...r 27,2008., "In our most recent discussion with ...
Breaking Biology Technology:Genmab Reaches Milestone in Ofatumumab Collaboration 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 2Stem Cell Leader Beike Signs 8 New Cooperation Agreements, Establishes Safety Monitoring Boards 3Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2
...s and government representatives have suggested a ...acted to stimulate investments in high-growth indu...Senate committee on Wednesday. For more on that he...investment in high-growth companies , ,Following ...Increasing from $30 million to $60 million the ava...
... sales of its consumables and scientific instrumen...eration to a larger facility here, the company rep...ific instruments and consumables used by research ...drug discovery and development process. , ,The new...one block from its old facility. , ,"This new fac...
...tives from universities in Germany and India and t...reement on Monday to begin a global master of busi... on the Internet. , ,The program further expands u...hat the borders of the state are the borders of th...s, the 15-month Global MBA program will begin in J...
...Technologies Inc. today announced that Abe Schwart...d down from the company,s board of directors in or...nt fund. The company does business as Merge Health... development assistance to the company beyond his ...,"While the decision to launch a new HCT fund requ...
Other Biology Technology:Suggestions offered to foster high-growth business investment 2UW-Oshkosh launching Global MBA with schools in Germany, India 2
...ins on a 1x3 inch nitrocellulose-coated glass slid...ccording to Gene Ontology classification, are arra...itional control proteins and a specific chip layou...Ichip protein microarrays are high-density protein...
...ained in standard 96-well microtiter plates. Each ...000 clones per plate. After positive identificatio...bplate is screened with a single 96-well PCR to id... well are then plated on LB/Amp agar and the resul...
... designed for flexibility and routine operation. W...on lens, true hyperbolic quadrupole and high-speed...idest range of sample types and applications. New ...nts unique ShieldTorch System, which enables the 7...
...plate luminescence reader that is designed for the...minescence labels: Reporter gene assays luciferas...ce substrates (luminol, acridinium esters, dioxeta...s (cytotoxity and proliferation, intracellular Ca2...
Biology Products: